Expand RNXT Menu
RNXT MENU

Renovorx (RNXT) closed at $1.04 on November 13, 2026, down 10.3% from the previous close, on volume of 814,439 shares (30-day average 438,630).

Key numbers
  • Last close: $1.04 (November 13, 2026)
  • 52-week range: $0.70 to $2.59
  • Market value: $46.9 million

Data as of November 13, 2026.

RNXT Stock Summary and Trading Ideas (Renovorx | NASDAQ:RNXT)

Charts for Today's Stock Price and Implied Volatility in Renovorx

Stock Price & Volume | Full Chart

Sentiment

News

RenovoRx Earnings Call Highlights Record Growth

TipRanks (Sat, 14-Nov 9:08 PM ET)

Trading Statistics

Key Ratios

Renovorx (RNXT) Frequently Asked Questions

What does Renovorx do?

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed for targeted therapeutic delivery across the arterial wall near the tumor site (known as intra-arterial, or IA delivery) to bathe the target tumor, while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

What symbol and exchange does Renovorx shares trade?

Renovorx trades on the NASDAQ stock market under the symbol RNXT.

What is Renovorx stock price doing today?

As of November 16, 2026, RNXT stock price declined to $0.98 with 552,755 million shares trading.

What is Renovorx's Beta?

RNXT has a beta of 1.20, meaning it tends to be more sensitive to market movements. RNXT has a correlation of 0.03 to the broad based SPY ETF.

How much is Renovorx worth?

RNXT has a market cap of $44.20 million. This is considered a Sub-Micro Cap stock.

How much money does Renovorx make?

Last quarter Renovorx reported $1 million in Revenue and -$.07 earnings per share. This beat revenue expectation by $4,400 and missed earnings estimates by -$.02.

What is the highest and lowest price Renovorx traded in the last 3 year period?

In the last 3 years, RNXT traded as high as $2.59 and as low as $.53.

What are the top ETFs holding Renovorx?

The top ETF exchange traded funds that RNXT belongs to (by Net Assets): VTI, VXF.

Is Renovorx (RNXT) a good investment?

RNXT has underperformed the market in the last year with a price return of +0.6% while the SPY ETF gained +11.4%. RNXT has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -22.2% and -26.3%, respectively, while the SPY returned -4.5% and -2.0%, respectively.

What are the support and resistance levels for Renovorx (RNXT)?

RNXT support price is $.97 and resistance is $1.11 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that RNXT shares will trade within this expected range on the day.

Market Data Delayed 15 Minutes